Phase II trial of neoadjuvant temozolomide in resectable melanoma patients.
Shah GD, Socci ND, Gold JS, Wolchok JD, Carvajal RD, Panageas KS, Viale A, Brady MS, Coit DG, Chapman PB.
Shah GD, et al. Among authors: coit dg.
Ann Oncol. 2010 Aug;21(8):1718-1722. doi: 10.1093/annonc/mdp593. Epub 2010 Jan 15.
Ann Oncol. 2010.
PMID: 20080829
Free article.
Clinical Trial.